The AMYLIN brand, founded in 2005 (United States), from 584 sister brands and 17477 competing brands. AMYLIN is a brand of ASTRAZENECA, listed on the stock exchange of London. The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. AMYLIN belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(AMYLIN)
over 5 years*
GBX 24,948.16